Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.
Cheng C, Wang D, Yu M, Zhai Y, Pan C, Liang B, Zhang J, Wang C, Yin Y, Li L, Wu F, Shi Z, Fan X, Liu X, Wang Z, Zhao Z, Li G, Jiang T, Zhang W; Chinese Glioma Genome Atlas (CGGA) Network.
Cheng C, et al.
Neurosurgery. 2023 Oct 1;93(4):802-812. doi: 10.1227/neu.0000000000002495. Epub 2023 Apr 18.
Neurosurgery. 2023.
PMID: 37070826
Free PMC article.